Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some d...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado |
Aporte de: |
id |
todo:paper_00086215_v344_n11_p1325_Prado |
---|---|
record_format |
dspace |
spelling |
todo:paper_00086215_v344_n11_p1325_Prado2023-10-03T14:07:19Z Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release Prado, H.J. Matulewicz, M.C. Bonelli, P.R. Cukierman, A.L. Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Dissolution Starch Turbidity Controlled drug delivery buffer ibuprofen polyelectrolyte starch article controlled drug release diffusion dissolution drug delivery system drug synthesis infrared spectroscopy measurement performance pH priority journal tablet tablet matrix turbidity Amylose Carbohydrate Sequence Carrageenan Diffusion Drug Carriers Electrolytes Ibuprofen Pharmaceutical Preparations Quaternary Ammonium Compounds Spectroscopy, Fourier Transform Infrared Starch Tablets A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some differences in comparison with either IPEC constituents or physical mixture. The swelling of tablets obtained by direct compression was independent of pH, and a maximum value of 742% was attained after 24 h. The performance of the IPEC as matrix for controlled release of ibuprofen indicates that drug delivery takes place in a zero-order manner. Experimental dissolution data in the buffer stage were properly represented by a model accounting for contributions of Fickian diffusion and relaxation phenomena; this model suggests that the former predominates over the latter, for the modeled range. © 2009 Elsevier Ltd. All rights reserved. Fil:Prado, H.J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Matulewicz, M.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Bonelli, P.R. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Cukierman, A.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Dissolution Starch Turbidity Controlled drug delivery buffer ibuprofen polyelectrolyte starch article controlled drug release diffusion dissolution drug delivery system drug synthesis infrared spectroscopy measurement performance pH priority journal tablet tablet matrix turbidity Amylose Carbohydrate Sequence Carrageenan Diffusion Drug Carriers Electrolytes Ibuprofen Pharmaceutical Preparations Quaternary Ammonium Compounds Spectroscopy, Fourier Transform Infrared Starch Tablets |
spellingShingle |
Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Dissolution Starch Turbidity Controlled drug delivery buffer ibuprofen polyelectrolyte starch article controlled drug release diffusion dissolution drug delivery system drug synthesis infrared spectroscopy measurement performance pH priority journal tablet tablet matrix turbidity Amylose Carbohydrate Sequence Carrageenan Diffusion Drug Carriers Electrolytes Ibuprofen Pharmaceutical Preparations Quaternary Ammonium Compounds Spectroscopy, Fourier Transform Infrared Starch Tablets Prado, H.J. Matulewicz, M.C. Bonelli, P.R. Cukierman, A.L. Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
topic_facet |
Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Dissolution Starch Turbidity Controlled drug delivery buffer ibuprofen polyelectrolyte starch article controlled drug release diffusion dissolution drug delivery system drug synthesis infrared spectroscopy measurement performance pH priority journal tablet tablet matrix turbidity Amylose Carbohydrate Sequence Carrageenan Diffusion Drug Carriers Electrolytes Ibuprofen Pharmaceutical Preparations Quaternary Ammonium Compounds Spectroscopy, Fourier Transform Infrared Starch Tablets |
description |
A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some differences in comparison with either IPEC constituents or physical mixture. The swelling of tablets obtained by direct compression was independent of pH, and a maximum value of 742% was attained after 24 h. The performance of the IPEC as matrix for controlled release of ibuprofen indicates that drug delivery takes place in a zero-order manner. Experimental dissolution data in the buffer stage were properly represented by a model accounting for contributions of Fickian diffusion and relaxation phenomena; this model suggests that the former predominates over the latter, for the modeled range. © 2009 Elsevier Ltd. All rights reserved. |
format |
JOUR |
author |
Prado, H.J. Matulewicz, M.C. Bonelli, P.R. Cukierman, A.L. |
author_facet |
Prado, H.J. Matulewicz, M.C. Bonelli, P.R. Cukierman, A.L. |
author_sort |
Prado, H.J. |
title |
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
title_short |
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
title_full |
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
title_fullStr |
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
title_full_unstemmed |
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
title_sort |
preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release |
url |
http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado |
work_keys_str_mv |
AT pradohj preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease AT matulewiczmc preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease AT bonellipr preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease AT cukiermanal preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease |
_version_ |
1782031019353833472 |